Heads of HTA Agencies Group convene in Lisbon for fourth meeting
HTA Agencies Meeting Updates: It seems the Heads of HTA Agencies Group had a productive meeting in Lisbon, Portugal. They discussed key strategic topics including the confirmation of the new Vice-Chair, updates on the HTA Regulation and long-term strategic planning for the group!
Next meeting will take place in Stockholm, Sweden in May 2023.
Recent Posts
Infarmed Regulatory Activity: January 2026 Highlights and Impacts on Market Access
Infarmed regulatory activity in January 2026 showcased robust performance by Portugal's National Authority for Medicines and Health Products, spanning marketing authorizations, clinical trials, public reimbursement, inspections, pharmacovigilance, and enforcement. The agency processed 45 renewals...
NICE Approves Ruxolitinib Cream for Treating Vitiligo with Facial Involvement
NICE Backs Ruxolitinib Cream Vitiligo Treatment
Ruxolitinib cream vitiligo therapy has received a major endorsement from the National Institute for Health and Care Excellence (NICE), which recommends it for non-segmental vitiligo with...
Economic Impact of Industry Clinical Trials in Europe
Industry clinical trials in are a vital engine of medical innovation and economic growth, with the European Economic Area (EEA) generating €35.7 billion in Gross Value Added (GVA) in 2025 from these activities. This includes €21.7 billion from direct, indirect, and induced effects, €3.6 billion f...